HIV-1 protease as a potential target for anti-AIDS therapy.
Meek
T D
TD
Department of Medicinal Chemistry, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Dreyer
G B
GB
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000595:Amino Acid Sequence; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D017320:HIV Protease Inhibitors; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D008969:Molecular Sequence Data; D011480:Protease Inhibitors / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000382:microbiology
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011480:Protease Inhibitors